ArticlePhotochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology2025
Glyphosate exposure did not increase the risk of UVR-induced skin tumors in hairless mice.
Article in Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Glyphosate (GLY) is the most widely used pesticide in the world. Agricultural workers are exposed to GLY via ingestion and skin contact. GLY may generate epigenetic changes that might be carcinogenic. However, whether GLY is carcinogenic remains controversial. We investigated whether GLY was co-carcinogenic with ultraviolet radiation (UVR) by monitoring skin tumor development in hairless mice. Four groups of immunocompetent mice (total, N = 96) were used in the study. Two groups received GLY in drinking water (5 µg/mL or 50 µg/mL), one group received 50 µL topical GLY (6.59% w/w) three times per week, and a UVR control group received only tap water. All groups were given UVR until they developed three 4-mm tumors or one 12-mm tumor. Times to development of first, second, and third skin tumors were recorded. In both groups given GLY orally (medians, 163 days) and the group given GLY topically (median, 170 days), the times to skin tumor development were not significantly different from the control group (median, 163 days; p ≥ 0.535). Mass spectrometry imaging showed that topically applied GLY was present on the surface of the skin but not detectable within the skin. There were no differences in weight, erythema, or pigmentation. When combined with UVR, GLY in drinking water or directly applied to skin was not associated with increased skin tumor development.
Indexed as
Identifiers
41073844What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.